Clinical Trials Browser

Phase 2 × INDUSTRY × Malignant Ascites × Clear all

NCT06266091 2025-07-20

Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

Phase 2 Completed

Malignant Ascites